Followers | 47 |
Posts | 12040 |
Boards Moderated | 0 |
Alias Born | 09/12/2017 |
Thursday, July 11, 2019 11:25:29 PM
g. The following is a complete list of third party providers, including names and addresses, engaged by the Company, its officers, directors or controlling shareholders, during the period from the Company’s prior fiscal year end to the date of this OTCQB Certification, to provide investor relations services, public relations services, marketing, brand awareness, consulting, stock promotion, or any other related services to the Company.
JH Darbie & Co., Inc., Marc Deutch, 40 W Wall St., 30TH Floor New York, New York 10005
https://backend.otcmarkets.com/otcapi/company/financial-report/215404/content
Reality- CHARGES
JH Darbie Charged in Calissio Resources Scam 101
https://www.securitieslawyer101.com/2018/jh-darbie-charged-calissio-resources-scam/
Reality- 9 FINRA Regulatory Events
https://files.brokercheck.finra.org/firm/firm_43520.pdf
Reality- SEC Administrative Proceeding
ADMINISTRATIVE PROCEEDING File No. 3-18409
In the Matter of
JH DARBIE & CO., INC., and ROBERT Y. RABINOWITZ
Respondents
Respondents
1. JH Darbie is a New York corporation with its principal place of business in New York, New York. During the Relevant Period, JH Darbie was registered with the Commission as a broker-dealer.
2. Rabinowitz, age 45, lives in Livingston, New Jersey. A New Jersey certified public accountant, Rabinowitz founded JH Darbie in 1997 and is a seventy-six percent owner of the firm. During the Relevant Period, and continuing today, he served as its CEO and FINOP, holding Series 7, Series 24 and Series 27 licenses, among others.
https://www.sec.gov/litigation/admin/2018/34-82951.pdf
Rabinowitz is a NJ guy doing business in NY
Reality- CHARGES
JH Darbie Charged in Calissio Resources Scam 101
https://www.securitieslawyer101.com/2018/jh-darbie-charged-calissio-resources-scam/
Reality- 9 FINRA Regulatory Events
https://files.brokercheck.finra.org/firm/firm_43520.pdf
Reality- SEC Administrative Proceeding
ADMINISTRATIVE PROCEEDING File No. 3-18409
In the Matter of
JH DARBIE & CO., INC., and ROBERT Y. RABINOWITZ
Respondents
Respondents
1. JH Darbie is a New York corporation with its principal place of business in New York, New York. During the Relevant Period, JH Darbie was registered with the Commission as a broker-dealer.
2. Rabinowitz, age 45, lives in Livingston, New Jersey. A New Jersey certified public accountant, Rabinowitz founded JH Darbie in 1997 and is a seventy-six percent owner of the firm. During the Relevant Period, and continuing today, he served as its CEO and FINOP, holding Series 7, Series 24 and Series 27 licenses, among others.
https://www.sec.gov/litigation/admin/2018/34-82951.pdf
Rabinowitz is a NJ guy doing business in NY
Recent CELZ News
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM